8.1 Henderson-Hasselbalch Equation, Buffer Systems & Acid-Base Disorders

8.1 Henderson-Hasselbalch Equation, Buffer Systems & Acid-Base Disorders

[!NOTE] Clinical Significance of Hydrogen Ion Regulation: Precise control of extracellular fluid hydrogen ion concentration ([H+]) is essential for survival. Hydrogen ions alter the ionization states of amino acid functional groups (such as histidine, cysteine, and glutamate), dictating the three-dimensional conformation and catalytic activity of critical enzymes, membrane transport channels, and cellular receptors. While major electrolytes like sodium and chloride circulate at millimolar concentrations (10^-3 mol/L), circulating free hydrogen ions exist at minute nanomolar concentrations (10^-9 mol/L). Despite this minute abundance, even slight deviations in [H+] disrupt cardiac contractility, vascular tone, neurological transmission, and electrolyte distribution.

---

Chemical Fundamentals of Acid-Base Balance

In aqueous solutions, acidity is quantified by the activity or concentration of free hydrogen ions ([H+]), conventionally expressed on a logarithmic scale defined by Peter Lauritz Sørensen in 1909 as pH:

$\text{pH} = -\log_{10}[\text{H}^+]$

$\text{or conversely: } [\text{H}^+] = 10^{-\text{pH}}$

Because pH is inversely and logarithmically related to [H+], an increase in hydrogen ion concentration causes a fall in pH, and a decrease in hydrogen ion concentration causes a rise in pH. Crucially, because the scale is base-10 logarithmic, a change of 1.0 pH unit corresponds to a tenfold change in [H+], and a shift of 0.3 pH units represents a doubling or halving of [H+].

+-----------------------------------------------------------------------------------------+
|                   Logarithmic Relationship Between pH and [H+]                          |
+-----------------------------------------------------------------------------------------+
|  pH Value      [H+] (mol/L)         [H+] (nmol/L)        Clinical Classification        |
+-----------------------------------------------------------------------------------------+
|  7.00          1.00 x 10^-7         100 nmol/L           Severe, life-threatening acidemia|
|  7.20          6.31 x 10^-8          63 nmol/L           Moderate acidemia              |
|  7.35          4.47 x 10^-8          45 nmol/L           Lower limit of normal arterial |
|  7.40          3.98 x 10^-8          40 nmol/L           Optimal physiological baseline |
|  7.45          3.55 x 10^-8          35 nmol/L           Upper limit of normal arterial |
|  7.55          2.82 x 10^-8          28 nmol/L           Moderate alkalemia            |
|  7.70          2.00 x 10^-8          20 nmol/L           Severe, life-threatening alkalemia|
+-----------------------------------------------------------------------------------------+

Terminology: Acidemia vs. Acidosis, Alkalemia vs. Alkalosis

In laboratory medicine and clinical pathology, precise distinction between physiological state and pathological process is critical:

• Acidemia: Refers strictly to the state of blood pH being abnormally low (< 7.35), representing an arterial [H+] > 45 nmol/L.
• Alkalemia: Refers strictly to the state of blood pH being abnormally high (> 7.45), representing an arterial [H+] < 35 nmol/L.
• Acidosis: Refers to a pathological process or condition that tends to add acid or remove base from extracellular fluid (e.g., diabetic ketoacidosis, renal failure). A patient may have an underlying acidosis yet exhibit a normal blood pH if full physiological compensation has occurred or if a coexisting alkalosis offsets the acid load.
• Alkalosis: Refers to a pathological process or condition that tends to add base or remove acid from extracellular fluid (e.g., protracted vomiting, primary hyperaldosteronism, hyperventilation). A patient may have an active alkalosis while their blood pH remains in the normal reference interval.

---

The Henderson-Hasselbalch Equation & The 20:1 Ratio

The central mathematical model governing clinical acid-base interpretation is the Henderson-Hasselbalch equation, derived from the equilibrium expression for the dissociation of weak carbonic acid (H2CO3):

$\text{CO}_2 + \text{H}_2\text{O} \rightleftharpoons \text{H}_2\text{CO}_3 \rightleftharpoons \text{H}^+ + \text{HCO}_3^-$

Because the concentration of undissociated carbonic acid (H2CO3) in blood is extraordinarily small (approximately 1 molecule of H2CO3 for every 800 molecules of dissolved CO2), clinical chemists group dissolved gas (dCO2) and true H2CO3 into a single composite dissolved carbon dioxide term. The apparent dissociation constant (Ka') for this combined reaction in human plasma at 37.0°C is 7.94 × 10^-7 mol/L, which corresponds to a pKa' of 6.1.

The Mathematical Derivation

According to the law of mass action:

$K_a' = \frac{[\text{H}^+][\text{HCO}_3^-]}{[\text{dCO}_2]}$

Solving for [H+] yields the Henderson equation:

$[\text{H}^+] = K_a' \times \frac{[\text{dCO}_2]}{[\text{HCO}_3^-]} = 24 \times \frac{\text{pCO}_2}{[\text{HCO}_3^-]}$

Taking the negative logarithm (-log10) of both sides yields the classical Henderson-Hasselbalch equation:

$\text{pH} = \text{p}K_a' + \log_{10}\left( \frac{[\text{Base}]}{[\text{Acid}]} \right) = 6.1 + \log_{10}\left( \frac{[\text{HCO}_3^-]}{[\text{dCO}_2]} \right)$

Carbon Dioxide Solubility Coefficient (α)

Dissolved carbon dioxide in plasma ([dCO2]) is directly proportional to the partial pressure of carbon dioxide (pCO2) in contact with the blood, governed by Henry's law. The solubility coefficient of carbon dioxide (α) in plasma at normal body temperature (37.0°C) is 0.0307 mmol/L per mmHg (frequently rounded to 0.03 in clinical calculations):

$[\text{dCO}_2] = \alpha \times \text{pCO}_2 = 0.0307 \times \text{pCO}_2$

Substituting this term directly into the Henderson-Hasselbalch equation yields:

$\text{pH} = 6.1 + \log_{10}\left( \frac{[\text{HCO}_3^-]}{0.0307 \times \text{pCO}_2} \right)$

The Normal 20:1 Ratio

Inserting typical resting arterial blood values ([HCO3-] = 24.0 mmol/L and pCO2 = 40.0 mmHg):

1. Calculate dissolved CO2: [dCO2] = 0.0307 mmol/L/mmHg × 40.0 mmHg = 1.228 mmol/L ≈ 1.2 mmol/L
2. Calculate the base-to-acid molar ratio: Ratio = [HCO3-] / [dCO2] = 24.0 mmol/L / 1.20 mmol/L = 20 / 1
3. Calculate the logarithm of the ratio: log10(20) = 1.3010 ≈ 1.30
4. Calculate the resulting pH: pH = 6.10 + 1.30 = 7.40

+-----------------------------------------------------------------------------------------+
|              The Henderson-Hasselbalch Seesaw: The Critical 20:1 Ratio                  |
+-----------------------------------------------------------------------------------------+
|                                                                                         |
|               [HCO3-] = 24 mmol/L (Kidneys)                                             |
|               ▲                                                                         |
|               │                 pH = 7.40                                               |
|       ┌───────┴───────┐      (Ratio = 20:1)         ┌───────────────┐                   |
|       │  BASE (MET)   │             ▲               │  ACID (RESP)  │                   |
|       └───────────────┘             │               └───────┬───────┘                   |
|       ══════════════════════════════╧═══════════════════════│════════                   |
|                                                             ▼                           |
|                                            dCO2 = 0.0307 x pCO2 = 1.2 mmol/L (Lungs)    |
|                                                                                         |
|  * If Ratio < 20:1 (due to [HCO3-] ↓ or pCO2 ↑) ──> pH < 7.40  ==>  ACIDOSIS             |
|  * If Ratio > 20:1 (due to [HCO3-] ↑ or pCO2 ↓) ──> pH > 7.40  ==>  ALKALOSIS            |
+-----------------------------------------------------------------------------------------+

Key Takeaway for Board Examinations: Blood pH is not governed by the absolute quantity of bicarbonate or carbon dioxide, but solely by the ratio of bicarbonate to dissolved carbon dioxide. If both bicarbonate and dissolved carbon dioxide increase or decrease proportionally such that the 20:1 ratio is preserved, blood pH remains precisely 7.40.

---

Physiological Buffer Systems in Blood & Tissues

A chemical buffer consists of a mixture of a weak acid and its conjugate base (or a weak base and its conjugate acid) that resists changes in hydrogen ion concentration when strong acids or bases are added. The buffering capacity of any weak acid system is maximized at a pH equal to its pKa, operating effectively within a range of ± 1.0 pH unit around that pKa.

In human physiology, four major buffer systems operate cooperatively across extracellular and intracellular fluid compartments:

+-----------------------------------------------------------------------------------------+
|                       Summary of Physiological Buffer Systems                           |
+-----------------------------------------------------------------------------------------+
| Buffer System        Compartment       pKa      Major Components         Clinical Role  |
+-----------------------------------------------------------------------------------------+
| Bicarbonate-Carbonic Extracellular    6.1      HCO3- (base) /           Primary ECF     |
| Acid System          Fluid (Plasma)            H2CO3 + dCO2 (acid)      buffer; open sys|
|                                                                                         |
| Hemoglobin System    Intracellular    6.8      Deoxy-Hb (base) /        Primary blood   |
|                      (Erythrocyte)    7.8      Oxy-Hb + H-Hb (acid)     non-HCO3 buffer |
|                                                                                         |
| Phosphate System     Intracellular &  6.8      HPO4 2- (base) /         Primary urinary |
|                      Renal Tubules             H2PO4 - (acid)           titratable acid |
|                                                                                         |
| Plasma Proteins      Extracellular    Var.     Protein- (base) /        Albumin ampho-  |
|                      (Serum)          (~7.4)   H-Protein (acid)         teric buffering |
+-----------------------------------------------------------------------------------------+

1. The Bicarbonate-Carbonic Acid System (Primary Extracellular Buffer)

Although the pKa of the bicarbonate system (6.1) is significantly lower than the physiological pH of blood (7.40)—suggesting poor chemical buffering capacity in a closed test tube—it is the most powerful and physiologically dominant extracellular buffer in the body. This unique power arises because it operates as an open physiological system:

• Independent Regulation: The acid component (pCO2) is regulated continuously by the respiratory system via changes in alveolar ventilation, while the base component ([HCO3-]) is regulated independently by the kidneys via tubular reabsorption and regeneration.
• Infinite Reservoir: Carbon dioxide is an end-product of oxidative cellular metabolism, continuously generated and readily exhaled. When strong fixed acid (such as lactic acid or β-hydroxybutyric acid) enters the extracellular fluid, bicarbonate neutralizes the free protons: H+ + HCO3- → H2CO3 → H2O + CO2 ↑ The resulting carbon dioxide does not accumulate to drive the reaction in reverse; instead, it is immediately expelled by the lungs, allowing continuous buffering until bicarbonate stores are exhausted.

2. The Hemoglobin Buffer System (Primary Blood Non-Bicarbonate Buffer)

Hemoglobin accounts for approximately 80% of the non-bicarbonate buffering capacity of whole blood, functioning as the premier intracellular buffer of the vascular space:

• Histidine Imidazole Residues: The buffering action of hemoglobin is mediated primarily by the imidazole functional groups of its 38 histidine residues per tetramer. The pKa of these imidazole groups ranges between 6.8 and 7.8, positioning them right across physiological blood pH.
• The Haldane Effect and Isohydric Transport: Deoxygenated hemoglobin (deoxy-Hb) is a significantly weaker acid (and stronger base) than oxygenated hemoglobin (oxy-Hb). As red blood cells circulate through systemic capillary beds, oxy-Hb releases oxygen to tissues. Concurrently, tissue CO2 diffuses into erythrocytes, where intracellular carbonic anhydrase rapidly hydrates it to H2CO3, which dissociates into H+ and HCO3-. The deoxy-Hb immediately binds the free H+ on its histidine residues, preventing intracellular acidification: H+ + HbO2- ⇌ H-Hb + O2 ↑
• The Chloride Shift (Hamburger Phenomenon): As intra-erythrocytic bicarbonate accumulates from CO2 hydration, a concentration gradient drives HCO3- out of the erythrocyte into plasma via the anion exchanger 1 (AE1 / Band 3) protein. To maintain intracellular electrical neutrality, chloride (Cl-) shifts from plasma into the erythrocyte in an exact 1:1 molar exchange. In pulmonary capillaries, the process reverses: oxygenation of hemoglobin releases protons, driving bicarbonate back into the red cell (while chloride exits) to form CO2, which diffuses into alveoli for expiration.

3. The Phosphate Buffer System

The inorganic phosphate buffer consists of the dibasic phosphate anion (HPO4 2-, conjugate base) and the monobasic phosphate anion (H2PO4 -, weak acid):

H+ + HPO4 2- ⇌ H2PO4 -

• Optimal Physiological pKa: With a pKa of 6.8, the phosphate system is chemically well-suited for buffering around pH 7.40.
• Extracellular Limitation: In plasma, total inorganic phosphate concentration is low (approximately 0.80 - 1.45 mmol/L), making its contribution to plasma buffering negligible compared to bicarbonate.
• Intracellular & Renal Tubular Dominance: Phosphate is concentrated intracellularly (in nucleic acids, ATP, phosphorylated intermediates), serving as a vital cytosolic buffer. In renal tubular fluid, where glomerular filtrate becomes concentrated and acidified, filtered HPO4 2- serves as the primary titratable acid, capturing secreted H+ ions to form H2PO4 -, which is excreted in the urine.

4. The Plasma Protein Buffer System

Plasma proteins, dominated quantitatively by albumin (approx. 40 g/dL), function as amphoteric polyampholytes capable of accepting or donating protons depending on ambient pH:

• Buffering Moieties: At physiological pH 7.40, proteins possess a net negative charge. Buffering is mediated by ionizable functional groups on amino acid side chains, particularly the 16 imidazole histidine groups on human serum albumin, as well as terminal α-amino and carboxyl groups.
• Clinical Relevance: In hypoalbuminemia, the non-bicarbonate buffering capacity of plasma is significantly diminished, which also alters the baseline serum anion gap.

---

The Four Primary Acid-Base Disturbances

Acid-base disorders are classified according to whether the primary driving defect is metabolic (involving bicarbonate) or respiratory (involving carbon dioxide partial pressure):

+-----------------------------------------------------------------------------------------+
|                   The Four Primary Acid-Base Disturbances                               |
+-----------------------------------------------------------------------------------------+
| Disorder               Primary Event       Initial Ratio   Compensatory Response        |
+-----------------------------------------------------------------------------------------+
| Metabolic Acidosis     ↓ [HCO3-]           < 20:1          Hyperventilation (↓ pCO2)    |
| Metabolic Alkalosis    ↑ [HCO3-]           > 20:1          Hypoventilation (↑ pCO2)     |
| Respiratory Acidosis   ↑ pCO2              < 20:1          Renal H+ excretion /         |
|                                                            HCO3- retention (↑ [HCO3-])  |
| Respiratory Alkalosis  ↓ pCO2              > 20:1          Renal HCO3- excretion /      |
|                                                            H+ retention (↓ [HCO3-])     |
+-----------------------------------------------------------------------------------------+

1. Metabolic Acidosis

• Primary Defect: A reduction in extracellular bicarbonate concentration ([HCO3-] < 22 mmol/L). This stems from the excessive accumulation of fixed non-volatile acids (which consume bicarbonate), excessive loss of bicarbonate via the gastrointestinal tract or kidneys, or rapid dilution of extracellular fluid.
• Impact on Ratio: The numerator of the Henderson-Hasselbalch ratio falls, driving the ratio below 20:1 and producing an arterial pH < 7.35.

2. Metabolic Alkalosis

• Primary Defect: An elevation in extracellular bicarbonate concentration ([HCO3-] > 26 mmol/L). This arises from excessive loss of non-volatile acid (e.g., loss of gastric hydrochloric acid through severe vomiting or nasogastric suction), exogenous administration of alkali (sodium bicarbonate, citrate in massive transfusions), or contraction alkalosis driven by renal mineralocorticoid activation.
• Impact on Ratio: The numerator increases, driving the ratio above 20:1 and resulting in an arterial pH > 7.45.

3. Respiratory Acidosis

• Primary Defect: Alveolar hypoventilation leading to retention of carbon dioxide and an elevation in arterial partial pressure of CO2 (pCO2 > 45 mmHg). Common causes include central nervous system depression (opioid overdose), neuromuscular weakness (myasthenia gravis, Guillain-Barré), chest wall deformities, and severe obstructive airway disease (COPD, acute severe asthma).
• Impact on Ratio: The denominator of the Henderson-Hasselbalch equation increases, driving the ratio below 20:1 and causing an arterial pH < 7.35.

4. Respiratory Alkalosis

• Primary Defect: Alveolar hyperventilation causing excessive pulmonary elimination of carbon dioxide and a reduction in arterial pCO2 (< 35 mmHg). Etiologies include psychogenic hyperventilation (acute anxiety), pulmonary embolism, hypoxia-driven respiratory drive (high altitude, pneumonia), early gram-negative sepsis, and direct stimulation of the medullary respiratory center by salicylates or hepatic encephalopathy.
• Impact on Ratio: The denominator decreases, driving the ratio above 20:1 and resulting in an arterial pH > 7.45.

---

Mechanisms and Kinetics of Physiological Compensation

When a primary acid-base disturbance occurs, the body mobilizes secondary physiological homeostatic mechanisms to return the base-to-acid ratio toward 20:1, thereby mitigating harmful shifts in pH.

The Cardinal Rules of Compensation

1. The Body Never Overcompensates: A compensatory physiological response never drives blood pH beyond the normal reference interval (7.35–7.45) in the opposite direction. For instance, in primary metabolic acidosis, compensatory hyperventilation will never elevate pH to 7.48. If the pH crosses the 7.45 boundary, a mixed acid-base disorder is present.
2. Complete vs. Partial Compensation:
   • Uncompensated (Acute): The primary abnormal parameter (pCO2 or [HCO3-]) has shifted, causing abnormal pH, while the secondary parameter remains within its normal reference interval.
   • Partially Compensated: The secondary organ system has altered its parameter in the same direction as the primary defect to restore the ratio, but arterial pH remains outside the 7.35–7.45 window.
   • Fully Compensated: The secondary compensatory response has successfully restored the 20:1 ratio, bringing arterial blood pH back within the normal reference interval (7.35–7.45), even though both pCO2 and [HCO3-] remain distinctly abnormal.

+-----------------------------------------------------------------------------------------+
|                     Kinetics and Pathways of Acid-Base Compensation                     |
+-----------------------------------------------------------------------------------------+
|  Physiological System    Onset Time      Peak Efficacy    Primary Effector Mechanism    |
+-----------------------------------------------------------------------------------------+
|  Chemical Buffers        Immediate       Seconds          Physicochemical proton binding|
|  (ECF & ICF)                                              (Hb, HCO3-, HPO4 2-, Protein) |
|                                                                                         |
|  Respiratory System      1 - 15 minutes  12 - 24 hours    Medullary & carotid body      |
|  (Alveolar Ventilation)                                   chemoreceptor-driven changes  |
|                                                           in minute ventilation (pCO2)  |
|                                                                                         |
|  Renal System            6 - 12 hours    24 - 72 hours    Tubular H+ secretion, HCO3-   |
|  (Kidneys)                                                reclamation, NH4+ synthesis   |
+-----------------------------------------------------------------------------------------+

Respiratory Compensation Kinetics & Mechanics

• Speed: Extremely rapid. Chemoreceptors detect changes in [H+] and pCO2 within seconds; adjustments in alveolar minute ventilation begin within 1 to 15 minutes and achieve maximal physiological compensation within 12 to 24 hours.
• Sensory Mechanism: Peripheral chemoreceptors (located in the carotid bodies at the bifurcation of the common carotid arteries and aortic arch bodies) respond primarily to circulating arterial [H+] and hypoxemia. Central chemoreceptors (located on the ventrolateral surface of the medulla oblongata) respond to [H+] generated within cerebrospinal fluid (CSF) by CO2 crossing the blood-brain barrier.
• Response to Metabolic Acidosis: Increased [H+] stimulates the medullary respiratory center to augment tidal volume and respiratory rate. This produces deep, rapid, unlabored breathing termed Kussmaul respirations (classically observed in severe DKA). Hyperventilation washes out alveolar CO2, lowering arterial pCO2 and reducing the denominator to restore the 20:1 ratio toward normal.
• Response to Metabolic Alkalosis: Elevated pH and [HCO3-] depress chemoreceptors, decreasing minute ventilation. Alveolar hypoventilation retains CO2, elevating arterial pCO2 to balance the elevated [HCO3-]. Physiological Limit: Hypoventilation is naturally constrained by arterial hypoxemia. When arterial pO2 drops below 50–60 mmHg, peripheral carotid chemoreceptors are strongly activated by hypoxemia, overriding alkalemic respiratory depression to prevent fatal asphyxiation. Consequently, respiratory compensation for metabolic alkalosis rarely drives pCO2 above 55–60 mmHg.

Renal Compensation Kinetics & Mechanics

• Speed: Delayed onset. While renal hemodynamic changes occur early, biochemical upregulation of tubular transport enzymes and ammoniagenesis requires 6 to 12 hours to initiate, requiring 24 to 72 hours (up to 3 to 5 days) to achieve maximal steady-state compensation.
• Proximal Convoluted Tubule (Bicarbonate Reclamation):
  • The glomeruli filter approximately 4,320 mmol of bicarbonate per day (180 L/day × 24 mmol/L). The proximal tubule reabsorbs 85% to 90% of this filtered load.
  • Apical Na+/H+ antiporters (NHE3) secrete H+ into the tubular lumen in exchange for luminal Na+.
  • Secreted H+ combines with filtered HCO3- to form H2CO3. Membrane-bound luminal Carbonic Anhydrase type IV (CA-IV) rapidly dehydrates H2CO3 into H2O and CO2.
  • Lipid-soluble CO2 diffuses passively across the apical membrane into the proximal tubular cell, where cytosolic Carbonic Anhydrase type II (CA-II) rehydrates it back to H2CO3, which dissociates into H+ and HCO3-.
  • Intracellular HCO3- is transported across the basolateral membrane into the peritubular capillary blood via the Na+-HCO3- cotransporter (NBCe1), while the intracellular H+ is recycled back through NHE3 into the lumen.
• Distal Convoluted Tubule & Collecting Duct (New Bicarbonate Generation):
  • Type A Intercalated Cells mediate active proton excretion via apical H+-ATPase and H+/K+-ATPase pumps, stimulated by aldosterone.
  • Titratable Acid Excretion: Secreted protons are buffered by filtered phosphate (HPO4 2- + H+ → H2PO4 -), which cannot be reabsorbed and is excreted in urine. For each proton excreted as titratable acid, one new molecule of HCO3- is synthesized and delivered to blood.
  • Ammoniagenesis (The Adaptive Engine): Proximal tubular cells metabolize glutamine into two ammonium ions (NH4+) and two α-ketoglutarate ions, which yield two new HCO3- molecules. In the collecting duct lumen, uncharged ammonia (NH3) diffuses into the urine, binds secreted H+ to form impermeant ammonium (NH4+), trapping it for excretion. During chronic respiratory acidosis, renal ammoniagenesis increases multifold, regenerating vast amounts of systemic bicarbonate.